Single-cell Omics: Emerging Technologies and Markets
The global single-cell omics market is expected to grow from $555.3 million in 2017 to nearly $1.6 billion in 2022, at a compound annual growth rate (CAGR) of 23.5% from 2017 to 2022.
- 71 tables
- An overview of the global markets and emerging technologies for single-cell genomics and proteomics
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Cell isolation technologies, including flow cytometry, laser capture microscopy, and micromanipulation
- Sample preparation technologies, including microfluidics, whole genome amplification/pre-amplification
- Analyses of next-generation sequencing, qPCR/PCR, microarrays, mass spectrometry, and microfluidics
- End-use industry coverage, including research, drug discovery and development, diagnostics, and applied
- Evaluation of the market's dynamics, including growth drivers, restraints, and opportunities
- Profiles of major players in the industry including 1 Cellbio, 10x Genomics Inc., Angle PLC, Aviva Biosciences, Boreal Genomics, Dolomite Bio and Hifibio
The scope of this report includes single cell analysis technologies, applications, industries, major funding initiatives, patents and companies. The market sizes for single cell products are given for the years 2015, 2016, 2017 (estimated) and 2022 (forecasted).
This report reviews the single cell workflow steps and technologies and provides background on why single cell analysis is important. It then discusses some of the top research initiatives that are contributing to single cell applications. Market driving forces are also discussed.
The structure of several important industry subsectors is reviewed, as well as major industry acquisitions and strategic alliances from Jan. 2016 to Sept. 2017. Industry subsectors analyzed include target enrichment, droplet digital PCR, single cell DNA polymerase, DNA amplification, next generation sequencing (NGS) instruments, single cell proteomics, circulating tumor cell (CTC) capture and detection, liquid biopsy, preimplantation testing and immune sequencing.
The market for single cell analysis technologies is analyzed in depth. The market is analyzed by end user, application field, product type, omics method used, cell type, clinical indication and geography.
Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the rest of the world.
Market data covers the years 2015, 2016, 2017 (estimated) and 2022 (forecast).
More than 90 companies in the single cell analysis industry are profiled in this report.
BCC Research provides a summary of the main industry acquisitions and strategic alliances from Jan. 2016 through Sept. 2017, including key alliance trends.
John Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with a nanotechnology/separations company. Bergin holds a B.S. degree in Chemistry, an M.S. degree in Biotechnology and a Master of Business Administration. John Bergin is a pseudonym of the author.
- Next Generation Cancer Diagnostics: Technologies and Global Markets (BIO081C)
- Rare Disease Diagnostics: Technologies and Global Markets (PHM227A)
- Agricultural Biotechnology: Emerging Technologies and Global Markets (BIO100D)
- Synthetic Biology: Global Markets (BIO066F)
- Global DNA Read, Write and Edit Market (BIO193A)
The global single-cell analysis market was valued at $541.2 million in 2014. This market is projected to grow from $626.2 million in 2015 to $1.6 billion in 2020, at a compound annual growth rate (CAGR) of 20.7% from 2015 to 2020.
- An overview of the global markets and emerging technologies for single-cell genomics and proteomics.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Cell isolation technologies including flow cytometry, laser capture microscopy, micromanipulation.
- Sample preparation technologies including microfluidics, whole genome amplification/ pre-amplification.
- Analyses of next generation sequencing, qPCR/PCR, microarrays, mass spectrometry, microfluidics.
- End use industry coverage including research, drug discovery and development, diagnostics, and applied.
- Evaluation of the market's dynamics including growth drivers, restraints, and opportunities.
- Profiles of major players in the industry.